Reaction

Liver Transplant Rejection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,787 reports · 49 co-occurring drugs

As of the last recalculation, Liver Transplant Rejection appears in 1,787 FAERS reports alongside 49 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 211.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Tacrolimus	1,100	211.2	212.7
Basiliximab	117	123.9	125.2
Tacrolimus Ointment 0.1%	761	123.2	124.0
Tacrolimus Extended-Release Capsules	761	122.9	123.6
Sirolimus	78	70.5	70.9
Mycophenolate Mofetil	563	70.0	70.3
Mycophenolate Mofetil Hydrochloride	563	69.9	70.2
Anti-Thymocyte Globulin (Rabbit)	43	63.6	63.9
Everolimus Tablets	77	55.9	56.1
Valganciclovir	65	41.6	41.8
Valganciclovir Hydrochloride	65	41.6	41.8
Mycophenolic Acid	102	39.3	39.4
Ganciclovir Sodium	34	38.1	38.2
Mycophenilic Acid	64	37.3	37.4
Ganciclovir	32	37.1	37.2
Valganciclovir Hydrochloride Powder,	35	34.1	34.2
Cyclosporine	250	30.3	30.3
Pyrazinamide	23	28.9	28.9
Ursosiol	40	24.5	24.5
Rifampicin	21	24.5	24.5
Ursodiol	43	23.5	23.6
Isoniazid	30	21.9	22.0
Everolimus	90	21.6	21.7
Entecavir	18	18.1	18.2
Prednisolone	244	18.1	18.1
Prednisolone Oral	244	18.1	18.1
Prednisolone Oral Solution	244	18.1	18.1
Sofosbuvir	30	18.0	18.0
Methylprednisolone	187	17.5	17.5
Ribavirin	86	16.3	16.3
Lamivudine Oral	32	15.0	15.0
Lamivudine	32	12.3	12.3
Azathioprine	79	10.9	10.9
Nystatin Ointment	23	10.3	10.3
Nystatin Cream	23	10.3	10.3
Prednisolone Acetate	9	10.2	10.2
Sulfamethoxazole And Trimethoprim	68	9.7	9.7
Efavirenz	9	9.4	9.5
Amphotericin B	9	8.4	8.4
Abacavir Sulfate	7	8.4	8.4
Micafungin Sodium	6	8.3	8.3
Rifampin	10	8.0	8.0
Elexacaftor, Tezacaftor, And Ivacaftor	7	6.6	6.6
Voriconazole Injection	12	6.5	6.5
Atezolizumab	19	5.7	5.8
Peginterferon Alfa-2A	22	4.8	4.8
Lumacaftor And Ivacaftor	3	4.1	4.1
Ledipasvir And Sofosbuvir	6	3.6	3.6
Dornase Alfa	4	2.4	2.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.